Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE
Dunsire Deborah received 7,751 Ultragenyx Pharmaceutical Inc. shares as an award (Form 4)
Traded May 14, 2026 · Filed May 18, 2026
On May 14, 2026, Dunsire Deborah (Director) received 7,751 Ultragenyx Pharmaceutical Inc. shares as an award, leaving 38,566 shares. Filed May 18, 2026 (Form 4).
- Awarded
- 7,751 shares
- Holding after
- 38,566 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 14, 2026 | Common Stock | Award | 7,751 | 38,566 | Direct |
Source
Related
- Ultragenyx Pharmaceutical Inc.
- Dunsire Deborah
- Ultragenyx Pharmaceutical Inc. shareholders
- Schedule 13G · Madison Avenue Partners, LP · Oct 20, 2026
- Form 4 · Horn Howard · Oct 19, 2026
- Form 4 · Huizenga Theodore Alan · Sep 15, 2026
- Form 4 · Huizenga Theodore Alan · Sep 8, 2026
- Schedule 13G · Rtw Investments, LP · Aug 14, 2026